Study Stopped
Study not activated, staff left institution.
Optimal Management of Urinary Catheter in Gyn Onc
Optimal Management and Timing of Removal of Urinary Catheter Following Pelvic Surgery by the Gynecologic Oncology Surgeon
1 other identifier
observational
N/A
1 country
1
Brief Summary
This is a combined retrospective observational study that will collect data on urinary catheter removal of patients who underwent pelvic surgery by a gynecologic oncologist to assess timing safety and its implications in postoperative care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2022
CompletedStudy Start
First participant enrolled
September 8, 2022
CompletedFirst Posted
Study publicly available on registry
September 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2023
CompletedMarch 17, 2023
March 1, 2023
6 months
September 8, 2022
March 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary retention rate after urinary catheter removal postoperatively
urinary retention rate will be measured as need for re-catheterization postoperatively
30 days after surgery
Study Arms (4)
Minimal invasive surgery
removal of urinary catheter postoperatively
Laparotomy
removal of urinary catheter postoperatively
Simple surgery
removal of urinary catheter postoperatively
Radical surgery
removal of urinary catheter postoperatively
Interventions
removal of urinary catheter less than 24 hours after surgery
removal of urinary catheter greater than 24 hours after surgery
Eligibility Criteria
patients who meets the eligibility criteria, undergoing pelvic surgery by a gynecologic oncologist. Simple and radical procedures included.
You may qualify if:
- Age above 18
- female gender
- undergoing pelvic surgery for benign or malignant indications by a gynecologic oncologist
You may not qualify if:
- Age less than 18 years of age at the time of surgery
- pregnant
- individual is a prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- WellSpan Healthlead
Study Sites (1)
WellSpan York Hospital
York, Pennsylvania, 17403, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Site Director, Gynecology Oncology
Study Record Dates
First Submitted
September 8, 2022
First Posted
September 13, 2022
Study Start
September 8, 2022
Primary Completion
March 14, 2023
Study Completion
March 14, 2023
Last Updated
March 17, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share